Science Letter
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Science Letter
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergy Medicine
Annexin 1-derived peptide Ac2-26 reduces allergic inflammation in rats
July 12th, 2005
The annexin 1-derived peptide Ac2-26 amerliorates allergic inflammation in a rat model. "Previous investigations have provided evidence that the N-terminal peptide of annexin 1 (peptide Ac2-26) has the capacity of reproducing the anti-inflammatory actions of the full-length protein in many systems," pharmacologists in Brazil explained. In their study, C. Bandeira-Melo and coauthors at the Oswaldo Cruz Foundation evaluated the "effectiveness of the peptide Ac2-26 as an antiallergic tool in a model of rat pleurisy," and sought to determine "some of the mechanisms involved." "In rats inflamed by injection of ovalbumin into the...
Source: Science Letter (2005-07-12)
|
